Gemmothérapie de Tilleul
Food supplement declared in France, declaration No 2023-4-523, decision dated 12 April 2023
Gemmothérapie de Tilleul (Disamare) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Tilia cordata 0.75 ml per day, miel. None of the rules we check flags an issue with its declared composition.
- Brand
- Disamare
- Food business operator placing the product on the market
- Giulia Ciaghi
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 0,75 ml
- Directions for use
- 5 à 15 gouttes par jour, en dehors des repas, pendant 21 jours
- Not recommended (according to the manufacturer)
- Breastfeeding women, Young children (aged 1 to 3), Pregnant women
Declaration 193448, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Tilia cordata Mill. | Feuille (bourgeon) | Autre macérât | 0.75 ml |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
Other ingredients
Eau potable, Alcool
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tilia cordata Mill.
Read the warning, when it applies and the studies cited
Linden - TILIA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).
Sources cited by Health Canada (2)
- De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Disamare
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gemmothérapie de Tilleul (Disamare): composition and regulation”, https://compoatlas.com/en/supplements/products/193448-gemmotherapie-de-tilleul, updated 15 November 2026.